Habit Reversal Training for Children and Adolescents With Trichotillomania
Primary Purpose
Trichotillomania
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Habit Reversal Training
Sponsored by
About this trial
This is an interventional treatment trial for Trichotillomania focused on measuring Habit Reversal Training, Hair Pulling, Children, Trich, cognitive behavioral therapy, TTM, psychotherapy
Eligibility Criteria
Inclusion Criteria:
- Outpatient children between the ages of 7-17 years.
- Meets DSM-IV criteria for a primary diagnosis of TTM
- English speaking
Exclusion Criteria:
- Lifetime DSM-IV bipolar, schizophrenia, or schizoaffective disorder, or substance abuse in past 6 months.
- A diagnosis of an autism spectrum disorders, mental retardation, or conduct disorder
- 1) Current clinically significant suicidal intent, or 2) individuals who have engaged in suicidal behaviors within 6 months
- Receiving concurrent psychotherapy or behavioral interventions. Families will have the option of discontinuing such services to enroll in the study. Those randomized to treatment as usual (TAU) will be able to continue or initiate psychosocial interventions whereas those randomized to HRT will not receive other interventions concurrent with HRT.
- Any change in established psychotropic medication (e.g., antidepressants, anxioloytics) within 4 weeks before study enrollment, any change in antipsychotics within 3 weeks prior to the screening assessment, any change in fluoxetine or atamoxetine within 6 weeks of study enrollment, and any change in alpha-2 agonists or stimulants within 1 week of study enrollment. Those randomized to TAU may make medication changes following randomization, including starting a medication; those randomized to HRT will remain stable on medications during the study.
- Unwillingness of parents to make the commitment to accompany their child for multiple study visits, unwillingness to take part in randomization, inability to attend weekly sessions as therapist availability allows, inability to attend assessment visits.
- Presence of a significant and/or unstable medical illness which might lead to hospitalization during the study.
Sites / Locations
- Rothman Center for Pediatric Neuropsychiatry
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
HRT group
TAU group
Arm Description
This group receives habit reversal training immediately.
This group receives treatment as usual for 8 weeks.
Outcomes
Primary Outcome Measures
Massachusetts General Hospital Hairpulling Scale (MGHHS)
This measure assesses the number of hair-pulling urges, the intensity of the urges, the ability of the patients to distract themselves from the urge to pull their hair, the number of hair-pulling incidents, attempts to resist hair-pulling, the ability to resist hair-pulling, and feeling uncomfortable about hair-pulling. Individual items are rated for severity from 0 (no symptoms) to 4 (extreme symptoms).
Secondary Outcome Measures
NIMH-TIS
The NIMH-TIS is a clinician rated scale (0-10 rating) measuring overall impairment produced by the time spent pulling or concealing damage, ability to control pulling, severity of alopecia, interference, and incapacitation caused by the pulling.
Full Information
NCT ID
NCT01445444
First Posted
September 29, 2011
Last Updated
March 9, 2016
Sponsor
University of South Florida
1. Study Identification
Unique Protocol Identification Number
NCT01445444
Brief Title
Habit Reversal Training for Children and Adolescents With Trichotillomania
Official Title
Habit Reversal Training for Children and Adolescents With Trichotillomania: A Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
March 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of South Florida
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the current study is:
To evaluate the effectiveness of a habit reversal training (HRT) approach for children ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania.
To explore factors that may relate to symptom severity, treatment outcome, and psychosocial impairment (e.g., specific symptom presence, co-morbidity, emotional regulation).
Detailed Description
The purpose of this research study is to further investigate how well Habit Reversal Training (HRT) works to reduce hair-pulling symptoms in children and adolescents with trichotillomania (TTM).
All children will have the option to receive 8 weekly HRT sessions. Half of all children will be chosen at random to receive these sessions immediately following the pre-assessment and the remaining half will receive them after eight weeks (TAU condition). These sessions will focus developing skills for managing TTM and to decrease hair pulling. Such skills may include teaching your child to replace hair-pulling with another behavior. In the TAU condition, participants will seek the treatment in the community, with the option of receiving HRT treatment sessions at the end of the study.
Participants in both groups will undergo four assessments in total (1) Pre-Assessment; (2) Post-treatment Assessment; (3) One-month Follow-up; (4)Three-month Follow-up. These assessments will involve several interviews that ask about different psychological symptoms that your child experiences such as sadness, anxiety, and TTM.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trichotillomania
Keywords
Habit Reversal Training, Hair Pulling, Children, Trich, cognitive behavioral therapy, TTM, psychotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
HRT group
Arm Type
Experimental
Arm Description
This group receives habit reversal training immediately.
Arm Title
TAU group
Arm Type
Active Comparator
Arm Description
This group receives treatment as usual for 8 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Habit Reversal Training
Other Intervention Name(s)
Trichotillomania, Hair pulling, TTM
Intervention Description
8 weekly therapy sessions lasting 50 minutes based on the protocol outlined by Woods (2001).
The overall focus of treatment is to provide patients with tools to help them manage and reduce hair-pulling.
components:
Session 1. (a) to develop an understanding of the subject's hair-pulling through an initial interview; and (b) to establish a protocol for ongoing assessment.
Session 2. implement habit reversal, including awareness training, competing response training, and social support.
Sessions 3-8. For subjects with a single hair-pulling site, Session 3 will review and practice HRT procedures and name solutions to problems that may have arisen. For those with multiple hair-pulling sites, treatment will be reviewed for the first site in the hierarchy.
Primary Outcome Measure Information:
Title
Massachusetts General Hospital Hairpulling Scale (MGHHS)
Description
This measure assesses the number of hair-pulling urges, the intensity of the urges, the ability of the patients to distract themselves from the urge to pull their hair, the number of hair-pulling incidents, attempts to resist hair-pulling, the ability to resist hair-pulling, and feeling uncomfortable about hair-pulling. Individual items are rated for severity from 0 (no symptoms) to 4 (extreme symptoms).
Time Frame
5 months
Secondary Outcome Measure Information:
Title
NIMH-TIS
Description
The NIMH-TIS is a clinician rated scale (0-10 rating) measuring overall impairment produced by the time spent pulling or concealing damage, ability to control pulling, severity of alopecia, interference, and incapacitation caused by the pulling.
Time Frame
5 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Outpatient children between the ages of 7-17 years.
Meets DSM-IV criteria for a primary diagnosis of TTM
English speaking
Exclusion Criteria:
Lifetime DSM-IV bipolar, schizophrenia, or schizoaffective disorder, or substance abuse in past 6 months.
A diagnosis of an autism spectrum disorders, mental retardation, or conduct disorder
1) Current clinically significant suicidal intent, or 2) individuals who have engaged in suicidal behaviors within 6 months
Receiving concurrent psychotherapy or behavioral interventions. Families will have the option of discontinuing such services to enroll in the study. Those randomized to treatment as usual (TAU) will be able to continue or initiate psychosocial interventions whereas those randomized to HRT will not receive other interventions concurrent with HRT.
Any change in established psychotropic medication (e.g., antidepressants, anxioloytics) within 4 weeks before study enrollment, any change in antipsychotics within 3 weeks prior to the screening assessment, any change in fluoxetine or atamoxetine within 6 weeks of study enrollment, and any change in alpha-2 agonists or stimulants within 1 week of study enrollment. Those randomized to TAU may make medication changes following randomization, including starting a medication; those randomized to HRT will remain stable on medications during the study.
Unwillingness of parents to make the commitment to accompany their child for multiple study visits, unwillingness to take part in randomization, inability to attend weekly sessions as therapist availability allows, inability to attend assessment visits.
Presence of a significant and/or unstable medical illness which might lead to hospitalization during the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adam B Lewin, Ph.D.
Organizational Affiliation
University of South Florida
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Omar Rahman, Ph.D.
Organizational Affiliation
University of South Florida
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rothman Center for Pediatric Neuropsychiatry
City
St. Petersburg
State/Province
Florida
ZIP/Postal Code
33701
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Habit Reversal Training for Children and Adolescents With Trichotillomania
We'll reach out to this number within 24 hrs